Beginning Cash: The amount of cash reported by the company on its previous statement.
Quince Therapeutics, Inc. (QNCX) had Beginning Cash of $5.81M for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
-- |
|
$-75.49M |
|
-- |
|
-- |
|
$79.78M |
|
$-79.78M |
|
$4.37M |
|
$-75.41M |
|
$-75.41M |
|
$-75.49M |
|
$-75.49M |
|
$-75.49M |
|
$-75.49M |
|
$-79.78M |
|
$-79.74M |
|
6.13M |
|
6.13M |
|
$-12.31 |
|
$-12.31 |
|
| Balance Sheet Financials | |
$123.41M |
|
$0.51M |
|
$0.58M |
|
$124.00M |
|
$8.50M |
|
-- |
|
$150.82M |
|
$159.32M |
|
$-35.32M |
|
$-35.32M |
|
$-35.32M |
|
1.02M |
|
| Cash Flow Statement Financials | |
$-26.51M |
|
$20.00M |
|
$118.38M |
|
|
Beginning Cash |
$5.81M |
$115.98M |
|
$110.17M |
|
$13.38M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
14.52 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-26.51M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
213.70% |
|
213.70% |
|
-60.88% |
|
213.70% |
|
$-34.73 |
|
$-4.32 |
|
$-4.32 |
|